3-hydroxy-3-methylglutaryl-coenzyme a has been researched along with Diabetes Mellitus, Type 2 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, JC; Kong, AP | 1 |
| An, CY; Gao, YY; Liu, XM; Sun, YM; Ying, S | 1 |
| Allan, J; Johnson, BF; LaBelle, P; Ronca, PD; Wilson, J; Zupkis, RV | 1 |
3 other study(ies) available for 3-hydroxy-3-methylglutaryl-coenzyme a and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Cancer risk in type 2 diabetes.
Topics: Acyl Coenzyme A; AMP-Activated Protein Kinase Kinases; Diabetes Mellitus, Type 2; Female; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Male; Metformin; Neoplasms; Oxidative Stress; Protein Serine-Threonine Kinases; Risk Factors; Transcription Factors | 2012 |
Effect of ScrF I polymorphism in the 2nd intron of the HMGCR gene on lipid-lowering response to simvastatin in Chinese diabetic patients.
Topics: Acyl Coenzyme A; Aged; China; Deoxyribonucleases, Type II Site-Specific; Diabetes Mellitus, Type 2; DNA Mutational Analysis; Female; Genetic Predisposition to Disease; Humans; Lipid Metabolism; Lipids; Male; Middle Aged; Polymorphism, Single Nucleotide; Simvastatin | 2007 |
Effects of lovastatin in diabetic patients treated with chlorpropamide.
Topics: Acyl Coenzyme A; Administration, Oral; Apolipoproteins B; Blood Glucose; Chlorpropamide; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Humans; Hypercholesterolemia; Lipoproteins, VLDL; Lovastatin; Male; Middle Aged; Time Factors | 1990 |